BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Apr 7, 2026; 32(13): 115649
Published online Apr 7, 2026. doi: 10.3748/wjg.v32.i13.115649
Figure 1
Figure 1 Study flow chart of patient selection. PBC: Primary biliary cholangitis; T2DM: Type 2 diabetes mellitus.
Figure 2
Figure 2 Kaplan-Meier survival analysis for liver-related mortality according to lean type 2 diabetes mellitus phenotype. A: Survival comparison among non-lean non-type 2 diabetes mellitus (T2DM), lean non-T2DM, non-lean T2DM, and lean T2DM groups (P < 0.001); B: Kaplan-Meier survival curves for non-lean non-T2DM and lean T2DM phenotype groups after propensity score matching. T2DM: Type 2 diabetes mellitus.
Figure 3
Figure 3 Forest plot showing hazard ratios and 95% confidence intervals for the stratified analysis of type 2 diabetes mellitus and lean interaction effects in primary biliary cholangitis patients. T2DM: Type 2 diabetes mellitus.
Figure 4
Figure 4 Propensity score distributions before and after matching between lean type 2 diabetes mellitus and non-lean non-type 2 diabetes mellitus primary biliary cholangitis patients. T2DM: Type 2 diabetes mellitus.
Figure 5
Figure 5 Covariate balance before and after propensity score matching between lean type 2 diabetes mellitus and non-lean non-type 2 diabetes mellitus groups. Alb: Albumin; PLT: Platelet; TBil: Total bilirubin; AMA-M2: Anti-mitochondrial antibody M2; INR: International normalized ratio; ALP: Alkaline phosphatase; ALT: Alanine aminotransferase.